Retraction: HBsAg Inhibits the Translocation of JTB into Mitochondria in HepG2 Cells and Potentially Plays a Role in HCC Progression (PLoS ONE (2012) 7:5 (e36914) DOI: 10.1371/journal.pone.0036914);HBsAg inhibits the translocation of JTB into mitochondria in HepG2 cells and potentially plays a role in HCC progression

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Liu, Yun Peng ^a   Yang, Xiao Ning ^a   Jazag, Amarsanaa ^c   Pan, Jin Shui ^a   Hu, Tian Hui ^b   Liu, Jing Jing ^a   Guleng, Bayasi ^a,b   Ren, Jian Lin ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c National Institute of Medical Research   (Mongolia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; HEPATITIS B SURFACE ANTIGEN; JUMPING TRANSLOCATION BREAKPOINT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL XL; PROTEIN KINASE B; RSK1 PROTEIN; SHORT HAIRPIN RNA; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; JTB PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN KINASE R; SMALL INTERFERING RNA; TUMOR PROTEIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL FUNCTION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION; GENE SILENCING; HEP-G2 CELL LINE; IN VITRO STUDY; JTB GENE; LIVER CELL CARCINOMA; MITOCHONDRION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; BIOSYNTHESIS; CELL MOTION; CELL STRAIN HEPG2; DISEASE COURSE; GENE TRANSLOCATION; GENETIC TRANSFECTION; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER MITOCHONDRION; LIVER TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; EIF-2 KINASE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HEP G2 CELLS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; MITOCHONDRIA, LIVER; NEOPLASM PROTEINS; PHOSPHORYLATION; RNA, SMALL INTERFERING; TRANSFECTION; TRANSLOCATION, GENETIC;

EID: 84872018766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0292101     Document Type: Erratum

References (37)

1. World Health Organization (2000) Hepatitis B Fact Sheet NO. 204 p.
2. Liu J, Fan D (2007) Hepatitis B in China. Lancet 369: 1582–1583.
3. Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45: 507–539.
4. Wang WH, Hullinger RL, Andrisani OM (2008) Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J Biol Chem 283: 25455–25467.
5. Martin-Vilchez S, Sanz-Cameno P, Rodriguez-Munoz Y, Majano PL, Molina-Jimenez F, et al. (2008) The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 47: 1872–1883.
6. Pang R, Lee TK, Poon RT, Fan ST, Wong KB, et al. (2007) Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 132: 1088–1103.
7. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, et al. (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59: 1145–1156.
8. Wang Y, Cui F, Lv Y, Li C, Xu X, et al. (2004) HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 39: 318–324.
9. Yang JC, Teng CF, Wu HC, Tsai HW, Chuang HC, et al. (2009) Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology 49: 1962–1971.
10. Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, et al. (2007) Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 133: 1466–1474.
11. Sugauchi F, Ohno T, Orito E, Sakugawa H, Ichida T, et al. (2003) Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol 70: 537–544.
12. Fan YF, Lu CC, Chang YC, Chang TT, Lin PW, et al. (2000) Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection. J Gastroenterol Hepatol 15: 519–528.
13. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, et al. (2001) Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33: 277–286.
14. Wang HC, Wu HC, Chen CF, Fausto N, Lei HY, et al. (2003) Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol 163: 2441–2449.
15. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, et al. (2004) Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25: 2023–2032.
16. Hung JH, Su IJ, Lei HY, Wang HC, Lin WC, et al. (2004) Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J Biol Chem 279: 46384–46392.
17. Wang HC, Chang WT, Chang WW, Wu HC, Huang W, et al. (2005) Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology 41: 761–770.
18. Hsieh YH, Su IJ, Wang HC, Tsai JH, Huang YJ, et al. (2007) Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1. Mol Cancer Res 5: 1063–1072.
19. Keung YK, Yung C, Wong JW, Shah F, Cobos E, et al. (1998) Unusual presentation of multiple myeloma with ‘‘jumping translocation’’ involving 1q21. A case report and review of the literature. Cancer Genet Cytogenet 106: 135–139.
20. Wong N, Chan A, Lee SW, Lam E, To KF, et al. (2003) Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression. J Hepatol 38: 298–306.
21. Hatakeyama S, Osawa M, Omine M, Ishikawa F (1999) JTB: a novel membrane protein gene at 1q21 rearranged in a jumping translocation. Oncogene 18: 2085–2090.
22. Kanome T, Itoh N, Ishikawa F, Mori K, Kim-Kaneyama JR, et al. (2007) Characterization of Jumping translocation breakpoint (JTB) gene product isolated as a TGF-beta1-inducible clone involved in regulation of mitochondrial function, cell growth and cell death. Oncogene 26: 5991–6001.
23. Pan JS, Cai JY, Xie CX, Zhou F, Zhang ZP, et al. (2009) Interacting with HBsAg compromises resistance of jumping translocation breakpoint protein to ultraviolet radiation-induced apoptosis in 293FT cells. Cancer Lett 285: 151–156.
24. Miyagishi M, Taira K (2002) U6 promoter-driven siRNAs with four uridine 39 overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20: 497–500.
25. Jazag A, Ijichi H, Kanai F, Imamura T, Guleng B, et al. (2005) Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta. Oncogene 24: 662–671.
26. Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, et al. (2005) Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65: 5864–5871.
27. Guleng B, Tateishi K, Kanai F, Jazag A, Ohta M, et al. (2005) Cancer-derived VEGF plays no role in malignant ascites formation in the mouse. World J Gastroenterol 11: 5455–5459.
28. HK, Susin SA, Penninger J, Kroemer G (1999) Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 6: 516–524.
29. Zamzami N, Kroemer G (2001) The mitochondrion in apoptosis: how Pandora’s box opens. Nat Rev Mol Cell Biol 2: 67–71.
30. Polimeno L, Capuano F, Marangi LC, Margiotta M, Lisowsky T, et al. (2000) The augmenter of liver regeneration induces mitochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mitochondria. Dig Liver Dis 32: 510–517.
31. Hildt E, Saher G, Bruss V, Hofschneider PH (1996) The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225: 235–239.
32. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, et al. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597–608.
33. Chen C, Edelstein LC, Gélinas C (2000) The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20: 2687–2695.
34. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, et al. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58: 1048–1051.
35. Sutherland C, Leighton IA, Cohen P (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296: 15–19.
36. Robinson MJ, Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180–186.
37. Schwabe RF, Brenner DA (2002) Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. Am J Physiol Gastrointest Liver Physiol 283: 204–211.